• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新兴流感病毒威胁:治疗和控制现状及新展望。

The emerging influenza virus threat: status and new prospects for its therapy and control.

机构信息

Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

Department of Respiratory Virology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.

出版信息

Arch Virol. 2018 Apr;163(4):831-844. doi: 10.1007/s00705-018-3708-y. Epub 2018 Jan 10.

DOI:10.1007/s00705-018-3708-y
PMID:29322273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7087104/
Abstract

Influenza A viruses (IAVs) are zoonotic pathogens that cause yearly outbreaks with high rates of morbidity and fatality. The virus continuously acquires point mutations while circulating in several hosts, ranging from aquatic birds to mammals, including humans. The wide range of hosts provides influenza A viruses greater chances of genetic re-assortment, leading to the emergence of zoonotic strains and occasional pandemics that have a severe impact on human life. Four major influenza pandemics have been reported to date, and health authorities worldwide have shown tremendous progress in efforts to control epidemics and pandemics. Here, we primarily discuss the pathogenesis of influenza virus type A, its epidemiology, pandemic potential, current status of antiviral drugs and vaccines, and ways to effectively manage the disease during a crisis.

摘要

甲型流感病毒(IAV)是一种人畜共患病病原体,可导致高发病率和死亡率的年度暴发。该病毒在包括人类在内的多种宿主中不断获得点突变,在从水生鸟类到哺乳动物的各种宿主中循环。宿主的广泛范围为甲型流感病毒提供了更大的遗传重配机会,导致了人畜共患病株的出现和偶尔的大流行,对人类生活造成了严重影响。迄今为止,已经报告了四起大流行,全世界的卫生当局在控制传染病和大流行方面取得了巨大进展。在这里,我们主要讨论甲型流感病毒的发病机制、流行病学、大流行潜力、当前抗病毒药物和疫苗的状况以及在危机期间有效管理疾病的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad3/7087104/5aa88923f67c/705_2018_3708_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad3/7087104/9dd5127af77e/705_2018_3708_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad3/7087104/8eb7ae1b11be/705_2018_3708_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad3/7087104/5aa88923f67c/705_2018_3708_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad3/7087104/9dd5127af77e/705_2018_3708_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad3/7087104/8eb7ae1b11be/705_2018_3708_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad3/7087104/5aa88923f67c/705_2018_3708_Fig3_HTML.jpg

相似文献

1
The emerging influenza virus threat: status and new prospects for its therapy and control.新兴流感病毒威胁:治疗和控制现状及新展望。
Arch Virol. 2018 Apr;163(4):831-844. doi: 10.1007/s00705-018-3708-y. Epub 2018 Jan 10.
2
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2012 Mar 16;87(11):97-108.
3
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2014 Mar 14;89(11):105-15.
4
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2013 Oct 18;88(42):449-63.
5
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2013 Mar 15;88(11):117-25.
6
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2012 Oct 19;87(42):401-12.
7
Passive immune neutralization strategies for prevention and control of influenza A infections.用于预防和控制甲型流感感染的被动免疫中和策略。
Immunotherapy. 2012 Feb;4(2):175-86. doi: 10.2217/imt.11.167.
8
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2015 Mar 20;90(12):109-20.
9
[Influenza, an existing public health problem].[流感,一个现存的公共卫生问题]
Salud Publica Mex. 2006 May-Jun;48(3):244-67. doi: 10.1590/s0036-36342006000300009.
10
Influenza: lessons from past pandemics, warnings from current incidents.流感:过去大流行的教训,当前事件的警示。
Nat Rev Microbiol. 2005 Aug;3(8):591-600. doi: 10.1038/nrmicro1208.

引用本文的文献

1
Fast and flu-rious: How to prevent and treat emerging influenza A viruses.快速且肆虐:如何预防和治疗新出现的甲型流感病毒
PLoS Pathog. 2025 May 16;21(5):e1013135. doi: 10.1371/journal.ppat.1013135. eCollection 2025 May.
2
Synergistic Antiviral Activity of Xanthan Gum and Camostat Against Influenza Virus Infection.黄原胶和抑肽酶对流感病毒感染的协同抗病毒活性
Viruses. 2025 Feb 21;17(3):301. doi: 10.3390/v17030301.
3
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy.

本文引用的文献

1
Preliminary Epidemiology of Human Infections with Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2017.中国2017年人感染高致病性甲型禽流感(H7N9)病毒的初步流行病学研究
Emerg Infect Dis. 2017 Aug;23(8):1355-1359. doi: 10.3201/eid2308.170640. Epub 2017 Aug 15.
2
Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China.中国人类感染高致病性甲型H7N9禽流感病毒
Emerg Infect Dis. 2017 Jul;23(8):1332-1340. doi: 10.3201/eid2308.170600. Epub 2017 Aug 15.
3
Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase.
免疫球蛋白制品对接受免疫球蛋白替代治疗的抗体免疫缺陷患者季节性流感感染和严重程度的影响。
Front Immunol. 2024 Oct 22;15:1452106. doi: 10.3389/fimmu.2024.1452106. eCollection 2024.
4
Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches.社论:针对新出现和再次出现的病毒性疾病的抗病毒选择:当前疗法、新型候选药物及新方法
Front Cell Infect Microbiol. 2024 Oct 17;14:1497018. doi: 10.3389/fcimb.2024.1497018. eCollection 2024.
5
Evolutionary Insights from Association Rule Mining of Co-Occurring Mutations in Influenza Hemagglutinin and Neuraminidase.从流感血凝素和神经氨酸酶共发生突变的关联规则挖掘中获得的进化见解。
Viruses. 2024 Sep 25;16(10):1515. doi: 10.3390/v16101515.
6
Could H5N1 bird flu virus be the cause of the next human pandemic?H5N1禽流感病毒会是下一次人类大流行的病因吗?
Front Microbiol. 2024 Oct 8;15:1477738. doi: 10.3389/fmicb.2024.1477738. eCollection 2024.
7
Unravelling the interaction between Influenza virus and the nuclear pore complex: insights into viral replication and host immune response.解析流感病毒与核孔复合体之间的相互作用:对病毒复制和宿主免疫反应的见解。
Virusdisease. 2024 Jun;35(2):231-242. doi: 10.1007/s13337-024-00879-6. Epub 2024 Jul 18.
8
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits Interaction.探索新一代嘧啶和吡啶衍生物作为靶向聚合酶PA-PB1亚基相互作用的抗流感药物。
Pharmaceutics. 2024 Jul 18;16(7):954. doi: 10.3390/pharmaceutics16070954.
9
Annexin A2: A Double-Edged Sword in Pathogen Infection.膜联蛋白A2:病原体感染中的一把双刃剑。
Pathogens. 2024 Jul 4;13(7):564. doi: 10.3390/pathogens13070564.
10
A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity.一种针对血凝素的小分子化合物抑制甲型流感病毒并具有广谱抗病毒活性。
Acta Pharmacol Sin. 2024 Nov;45(11):2380-2393. doi: 10.1038/s41401-024-01331-7. Epub 2024 Jul 10.
绿原酸抗甲型流感(H1N1/H3N2)病毒及其对神经氨酸酶的抑制作用
Sci Rep. 2017 Apr 10;7:45723. doi: 10.1038/srep45723.
4
History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines.通过接种疫苗控制流感的历史与演变:从首款单价疫苗到通用疫苗
J Prev Med Hyg. 2016 Sep;57(3):E115-E120.
5
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.流感病毒聚合酶复合物:其结构、功能及对抗病毒药物设计的意义的最新进展
Med Res Rev. 2016 Nov;36(6):1127-1173. doi: 10.1002/med.21401. Epub 2016 Aug 29.
6
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.一种识别所有甲型流感亚型的抗体的结构与功能分析
Cell. 2016 Jul 28;166(3):596-608. doi: 10.1016/j.cell.2016.05.073. Epub 2016 Jul 21.
7
Novel Reassortant Avian Influenza A(H5N6) Viruses in Humans, Guangdong, China, 2015.2015年中国广东人类感染新型重配甲型H5N6禽流感病毒
Emerg Infect Dis. 2016 Aug;22(8):1507-9. doi: 10.3201/eid2208.160146. Epub 2016 Aug 15.
8
Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know?流感患者胃肠道症状的患病率、临床意义及粪便样本中人类流感病毒的病理生理学:我们了解多少?
Virol J. 2015 Dec 12;12:215. doi: 10.1186/s12985-015-0448-4.
9
Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin.金耳糖醇,一种源自真菌的四氢呋喃,通过靶向流感病毒表面糖蛋白血凝素抑制流感病毒复制。
PLoS One. 2015 Oct 13;10(10):e0139236. doi: 10.1371/journal.pone.0139236. eCollection 2015.
10
Diagnostic Potential of Recombinant scFv Antibodies Generated Against Hemagglutinin Protein of Influenza A Virus.针对甲型流感病毒血凝素蛋白产生的重组单链抗体片段的诊断潜力
Front Immunol. 2015 Sep 2;6:440. doi: 10.3389/fimmu.2015.00440. eCollection 2015.